Showing results (691-700 of 709) with videos related to
Sort By:
Pageof 71
Journal of Crohn'S & Colitis|June 8, 2026
Histological activity predicts relapse in pediatric ulcerative colitis despite mucosal healing: a multicenter study from the pediatric IBD Porto group of ESPGHANIvana Trivić Mažuranić, Marina Aloi, Matteo Bramuzzo, et al.Nature|April 29, 2005
A giant gamma-ray flare from the magnetar SGR 1806-20D M Palmer, S Barthelmy, N Gehrels, et al.Journal of Pediatric Gastroenterology and Nutrition|September 9, 2022
Safety and Potential Efficacy of Escalating Dose of Ustekinumab in Pediatric Crohn Disease (the Speed-up Study): A Multicenter Study from the Pediatric IBD Porto Group of ESPGHANAnat Yerushalmy-Feler, Gemma Pujol-Muncunill, Javier Martin-de-Carpi, et al.Neuro-Oncology|December 28, 2023
IRE1 endoribonuclease signaling promotes myeloid cell infiltration in glioblastomaJoanna Obacz, Jérôme Archambeau, Elodie Lafont, et al.Inflammatory Bowel Diseases|January 15, 2025
Effectiveness and Safety of Adalimumab in Patients With Very Early-Onset Inflammatory Bowel Disease: A Retrospective Study on Behalf of the Porto Inflammatory Bowel Disease Working Group of European Society for Pediatric Gastroenterology Hepatology and NutritionYael Weintraub, Lauren V Collen, Seamus Hussey, et al.Science Advances|June 7, 2023
A structured jet explains the extreme GRB 221009ABrendan O'Connor, Eleonora Troja, Geoffrey Ryan, et al.Immunity|August 5, 2025
From complexity to consensus: A roadmap for neutrophil classificationLai Guan Ng, Ivan Ballesteros, Marco A Cassatella, et al.Journal of Crohn'S & Colitis|November 28, 2024
Upadacitinib for Induction of Remission in Pediatric Ulcerative Colitis: An International Multicenter StudyAnat Yerushalmy-Feler, Elizabeth A Spencer, Michael T Dolinger, et al.Alimentary Pharmacology & Therapeutics|February 8, 2025
Upadacitinib for Induction of Remission in Paediatric Crohn's Disease: An International Multicentre Retrospective StudyShlomi Cohen, Elizabeth A Spencer, Michael T Dolinger, et al.Haematologica|June 6, 2020
Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies: Improved outcomes over two decadesJason P Cooper, Barry E Storer, Noa Granot, et al.Pageof 71